skip to main content

Correlation between Maternal Characteristics and The Incidence of COVID-19 in Pregnant Woman: A Cross-Sectional Study

*Sekar Ayu Putri Utami  -  Faculty of Medicine, Sultan Agung Islamic University, Jl. Kaligawe Raya KM 4, Semarang, Indonesia, Indonesia
Rini Aryani  -  Department of Obstetric and Gynecology, Faculty of Medicine, Sultan Agung Islamic University, Jl. Kaligawe Raya KM 4, Semarang, Indonesia, Indonesia
Rita Kartika Sari  -  Department of Public Health, Faculty of Medicine, Sultan Agung Islamic University, Jl. Kaligawe Raya KM 4, Semarang, Indonesia, Indonesia

Citation Format:
Abstract

Background: COVID-19 is an infectious disease that attacks the respiratory tract. Pregnancy is considered as a risk factor because during pregnancy several physiological changes occur, namely increased expression of ACE2, changes in the respiratory system, and changes in the immune system, which make pregnant women more susceptible to SARS-CoV-2 infection. 

Objective: This study aims to determine the relationship between the characteristics of pregnant women and the incidence of COVID-19.

Methods: This observational analytic study used 51 samples of pregnant women, both infected with COVID-19 and those who were not, which were taken using a total sampling technique. The characteristics of pregnant women were taken through secondary data in the form of medical records at K.R.M.T. Wongsonegoro Regional Public Hospital Semarang, then analyzed univariately and bivariately using Spearman's test and contingency coefficient.

Results: The results obtained from the bivariate analysis were p = 0.863 (> 0.005) for the comorbid history variable, p = 0.367 (> 0.005) for the body mass index variable, and p = 0.423 (> 0.005) for the hypertension incident variable.

Conclusion: The results of this study concluded that there was no correlation between the characteristics of pregnant women (history of comorbidities, body mass index, and incidence of hypertension) with the incidence of COVID-19 in patients at K.R.M.T. Wongsonegoro Regional Public Hospital Semarang.

Fulltext View|Download
Keywords: COVID-19 , characteristics, maternal, pregnancy, pregnant

Article Metrics:

  1. Yuliana LW. Karakteristik gejala klinis kehamilan dengan Coronavirus disease (COVID-19). Jurnal Ilmiah Kesehatan Sandi Husada. 2020;12(2):726–34
  2. Han Y, Ma H, Suo M, Han F, Wang F, Ji J, et al. Clinical manifestation, outcomes in pregnant women with COVID-19 and the possibility of vertical transmission: A systematic review of the current data. J Perinat Med. 2020;48(9):912–24
  3. Zhao X, Jiang Y, Zhao Y, Xi H, Liu C, Qu F, et al. Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening. European Journal of Clinical Microbiology and Infectious Diseases. 2020;39(7):1209–20
  4. (POGI) PO dan GI. Rekomendasi Penanganan Infeksi Virus Corona (Covid-19) Pada Maternal (Hamil, Bersalin Dan Nifas) Revisi 2. Pokja Infeksi Saluran Reproduksi Perkumpulan Obstetri dan Ginekologi Indonesi a Tahun2020 [Internet]. 2020;3–15. Available from: https://pogi.or.id/publish/rekomendasi-penanganan-infeksi-virus-corona-covid-19-pada-maternal/
  5. Uygun-Can B, Acar-Bolat B. Clinical Properties and Diagnostic Methods of COVID-19 Infection in Pregnancies: Meta-Analysis. Biomed Res Int. 2020;2020
  6. Moore KM, Suthar MS. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19 . The COVID-19 resource centre is hosted on Elsevier Connect , the company ’ s public news and information. 2020;(January)
  7. Ramadhani HS, Islamy N, Yonata A. Covid-19 in Pregnancy: Is it Dangerous? Medical Journal of Lampung. 2020;10(2):318–23
  8. Turan O, Hakim A, Dashraath P, Jeslyn WJL, Wright A, Abdul-Kadir R. Clinical characteristics, prognostic factors, and maternal and neonatal outcomes of SARS-CoV-2 infection among hospitalized pregnant women: A systematic review. International Journal of Gynecology and Obstetrics. 2020;151(1):7–16
  9. Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: Living systematic review and meta-analysis. The BMJ. 2020;370
  10. Torres‐Torres J, Martinez‐Portilla RJ, Espino‐y‐Sosa S, Estrada‐Gutierrez G, Solis‐Paredes JM, Villafan‐Bernal JR, et al. Comorbidities, poverty and social vulnerability as risk factors for mortality in pregnant women with confirmed SARS‐CoV ‐2 infection: analysis of 13 062 positive pregnancies including 176 maternal deaths in Mexico. Ultrasound in Obstetrics & Gynecology. 2021;0–3
  11. Pathangey G, Fadadu PP, Hospodar AR, Abbas AE. The Pathophysiology of COVID-19 and SARS-CoV-2 Infection: Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapies. Am J Physiol Lung Cell Mol Physiol [Internet]. 2021 Mar 3 [cited 2022 Sep 1];320(3):L301. Available from: /pmc/articles/PMC7938645/
  12. Dalan R, Bornstein SR, El-armouche A, Rodionov RN, Markov A, Wielockx B, et al. The ACE-2 in COVID-19 : Foe or Friend ? Authors. 2020;
  13. Figueiro-Filho EA, Hobson SR, Farine D, Yudin MH. Highly expressed ACE-2 receptors during pregnancy: A protective factor for SARS-COV-2 infection? 2021; Available from: https://doi.org/10.1016/j.mehy.2021.110641
  14. Czeresnia RM, Teles A, Trad A, Schwach I, Britto W, Negrini R, et al. SARS-CoV-2 and Pregnancy: A Review of the Facts SARS-CoV-2 e gestação: uma revisão dos fatos. 2020; Available from: https://doi.org/
  15. Smith ER, Oakley E, Grandner GW, Rukundo G, Farooq F, Ferguson K, et al. Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: A sequential, prospective meta-analysis. Am J Obstet Gynecol. 2022 Aug;
  16. Schiffrin EL, Flack JM, Ito S, Muntner P, Webb RC. Hypertension and COVID-19. Am J Hypertens [Internet]. 2020;33(5):373. Available from: https://gisanddata.maps.arcgis

Last update:

No citation recorded.

Last update:

No citation recorded.